在接受放射治疗的头癌患者中,与治疗相关的唾液和味道变化评估 (TASTE):研究协议
Anja Dietze1,2, Peter J Neyer3, Marlene M Speth4
1Center for Radiation Oncology KSA-KSB, Cantonal Hospital Aarau, Aarau, Switzerland.
BMC cancer
|July 18, 2024
概括
头癌的放射治疗往往会改变口味,影响患者的生活质量. 这项研究调查了味道变化和唾液成分,以开发预防这种常见副作用的模型.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
- 生活质量研究 研究 生命质量研究
背景情况:
- 头癌的放射治疗经常导致味道变化,显著影响患者的生活质量 (QoL).
- 目前关于辐射诱导的味觉障碍的研究受限于小队列和多种方法,很少有研究区分味觉品质或与唾液组成相关的变化.
- 这项TASTE研究旨在通过调查味觉功能障碍及其与唾液变化的关系来解决这些差距.
研究的目的:
- 在接受放射治疗的头癌患者中全面评估味道,嗅觉和唾液功能.
- 开发一种正常组织并发症概率 (NTCP) 模型,用于晚期辐射相关的味觉障碍.
- 改善癌症患者对味觉功能障碍的理解和预防策略.
主要方法:
- 一项前性,观察性,多中心研究,涉及150名头癌患者.
- 用问卷,客观测试和唾液分析重复评估味觉,嗅觉和唾液功能.
- 主要终点:患者在辐射后12个月报告的味觉障碍;次要终点包括12个月和2年后的味道带评估.
主要成果:
- 数据收集正在进行中;结果将集中在患者报告的味觉障碍和客观味觉功能的测量上.
- 分析将探讨子组之间的差异和随着时间的推移而发生的变化,并根据年龄,性别和吸烟史等混因素进行调整.
- 将研究味觉障碍与辐射诱导的唾液成分变化之间的相关性.
结论:
- 这项研究旨在提高对头部和部放射治疗后的味觉障碍的理解.
- 这些发现可能有助于开发保存味道的放射治疗技术.
- 这项研究旨在减少头癌幸存者的长期味觉功能障碍负担.
相关概念视频
01:20Taste Buds and Receptors
1.9K
Gustation, or the sense of taste, is intrinsically linked to the anatomical structures located on the tongue. This organ's surface, along with the entirety of the oral cavity, is adorned with stratified squamous epithelium. Evident on the tongue are elevated structures known as papillae (singular = papilla), which house the mechanisms for the transduction of gustatory stimuli. Four distinct types of papillae exist, each identified by their unique morphological attributes: the circumvallate,...
1.9K
01:23Salivary Glands and Saliva
582
The salivary glands, of which there are three pairs known as the parotid, submandibular, and sublingual glands, play a crucial role in maintaining oral health and initiating the digestive process. Positioned near the ears, beneath the masseter muscle, the parotid glands secrete saliva into the oral cavity through the parotid duct of Stensen. Meanwhile, the submandibular glands, located on the floor of the mouth, secrete saliva through channels named submandibular ducts. The sublingual glands,...
582
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
191
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
191
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
158
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
158
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
209
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
209
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K